Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 23 peer-reviewed journal articles Updated
Neurology

Building a Standard of Care for Your Child

At a Glance

The standard of care for Congenital Muscular Dystrophy (CMD) requires a proactive, multidisciplinary medical team. Management focuses on preventing emergencies through early respiratory support, routine cardiac monitoring, nutritional assistance via G-tubes, and carefully managing anesthesia risks.

Managing Congenital Muscular Dystrophy (CMD) requires more than just a single doctor; it requires a “medical home” where a team of specialists works together. Current international guidelines, established by the European Neuromuscular Centre (ENMC), emphasize a proactive, multidisciplinary approach to care [1]. “Good care” means anticipating challenges before they become emergencies.

Respiratory Care and Vaccinations

In many forms of CMD, the muscles that help the lungs expand can be weak. This often shows up first during sleep, a condition called nocturnal hypoventilation.

  • Non-Invasive Ventilation (BiPAP): This is a small machine that uses a mask to help your child take deeper breaths while they sleep. It is often started well before a child has trouble breathing during the day [2][3].
  • Cough Assist (MI-E): When children with CMD get a cold, they may not have the strength to cough up mucus. A Mechanical Insufflation-Exsufflation (cough-assist) machine helps clear the airways, preventing pneumonia [4][5].
  • Aggressive Vaccination: Because respiratory infections are a leading cause of severe illness in CMD, keeping up-to-date with preventative respiratory vaccines (Flu, RSV, Pneumococcal) for the child and all household members is a vital first line of defense [6][7].

Cardiac Health: Watching the Heart

Some subtypes, particularly LMNA-related CMD, carry a high risk for heart rhythm problems (arrhythmias) or a weakened heart muscle (cardiomyopathy) [8][9].

  • Regular Monitoring: Children with these risks need frequent EKGs and echocardiograms [10].
  • Interventions: In some cases, a cardiologist may recommend a pacemaker or an implantable cardioverter-defibrillator (ICD) to protect the heart [11].

Nutrition and Growth

Weakness in the jaw and throat muscles can make eating exhausting. Doctors may use the medical term “failure to thrive” if your child is struggling to gain weight. This term can sound alarming or make parents feel at fault, but it is simply clinical terminology for slow growth caused by the physical effort required to eat.

  • Feeding Support: If a child spends hours trying to finish a meal or begins “aspirating” (inhaling food into the lungs), a Gastrostomy tube (G-tube) may be recommended [12][13].
  • Benefits: A G-tube ensures your child gets the calories they need for growth and prevents the lung infections caused by aspiration [14].

Orthopedic Care: Bone and Spine Health

Because the muscles supporting the spine are weak, many children with CMD develop scoliosis (a curve in the spine).

  • Surgical Management: If the curve becomes severe, surgery to fuse the spine may be necessary to protect lung function and improve the child’s ability to sit comfortably [15][16].
  • Contracture Management: Physical therapy and bracing are standard to help manage joint stiffness and maintain as much mobility as possible [17].

Critical Safety Warning for General Anesthesia: Children with neuromuscular conditions like CMD are at a uniquely high risk for severe complications from general anesthesia, including respiratory failure or prolonged intubation [18][19]. Always consult your neuromuscular team and insist on a specialized pediatric anesthesiologist before your child undergoes any procedure requiring anesthesia or sedation, including G-tube placement or scoliosis surgery.

The Horizon: Clinical Trials and Research

There is currently no cure for CMD. Medical management currently focuses entirely on alleviating symptoms and preserving function. However, we are in an era of rapid scientific advancement. Research into the “root cause” is ongoing:

  • LAMA2-RD: Scientists are investigating Laminin-111 replacement therapy and CRISPR-Cas9 to “turn on” genes that can compensate for the missing LAMA2 protein [20][21].
  • COL6-RD: Research is exploring gene-editing tools to “silence” the harmful genetic mutations [22].
  • Omigapil: This drug has been studied in pediatric trials to evaluate its safety and how it moves through the body in children with LAMA2 and Collagen VI subtypes [23].

Always discuss clinical trials with your child’s neurologist, as eligibility is often very specific to the child’s genetic mutation and age.

Common questions in this guide

What doctors should be on my child's CMD care team?
Children with CMD require a multidisciplinary medical home to manage their complex needs. This team typically includes a neurologist, pulmonologist, cardiologist, orthopedist, and a specialized pediatric anesthesiologist.
Why does my child with CMD need a sleep study?
Because the muscles that expand the lungs can be weak in CMD, breathing issues often show up first during sleep. A baseline sleep study checks for silent nighttime breathing trouble, known as nocturnal hypoventilation, so supportive treatments like a BiPAP machine can be started early.
What does 'failure to thrive' mean for a child with CMD?
Failure to thrive is a clinical term meaning a child is struggling to gain weight. In CMD, weakness in the jaw and throat muscles makes eating exhausting, meaning the child may burn more calories trying to eat than they actually take in.
When is a G-tube recommended for a child with CMD?
If a child spends hours trying to finish a meal, is failing to gain weight, or begins inhaling food into their lungs (aspirating), a G-tube is often recommended. It ensures the child gets enough calories to grow and prevents dangerous lung infections.
Why is general anesthesia dangerous for children with CMD?
Children with neuromuscular conditions like CMD have a uniquely high risk for severe complications from general anesthesia, including respiratory failure and prolonged intubation. Always consult your neuromuscular team and a specialized pediatric anesthesiologist before any procedure.
Are there treatments that address the root cause of CMD?
While there is currently no cure, medical management can greatly alleviate symptoms and preserve function. Additionally, ongoing clinical trials are researching gene-editing tools like CRISPR, gene replacement therapies, and new medications targeting specific CMD mutations.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Which members should be on our multidisciplinary team based on my child's specific subtype?
  2. 2.Is it time for a baseline sleep study to check for 'silent' nighttime breathing issues?
  3. 3.Does my child's subtype (like LMNA) require an EKG or echocardiogram every 6 months instead of once a year?
  4. 4.What is the threshold for considering a G-tube if my child is struggling with weight gain or long feeding times?
  5. 5.At what degree of spinal curvature do you typically recommend surgical intervention for scoliosis in CMD patients?
  6. 6.Who is the specialized pediatric anesthesiologist we should consult with before any procedure?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (23)
  1. 1

    283rd ENMC international workshop: Establishing expert care recommendations for LAMA2-RD: A prototype for the development of congenital muscular dystrophy subtype-specific care guidelines. Hoofddorp, The Netherlands, January 17th-19th 2025.

    Zambon AA, Klein A, Sarkozy A, et al.

    Neuromuscular disorders : NMD 2025; (55()):106220 doi:10.1016/j.nmd.2025.106220.

    PMID: 41106238
  2. 2

    Associative Increases in Amyotrophic Lateral Sclerosis Survival Duration With Non-invasive Ventilation Initiation and Usage Protocols.

    Khamankar N, Coan G, Weaver B, Mitchell CS

    Frontiers in neurology 2018; (9()):578 doi:10.3389/fneur.2018.00578.

    PMID: 30050497
  3. 3

    Amyotrophic Lateral Sclerosis and Noninvasive Positive Pressure Ventilatory Support: "Nasal Noninvasive Ventilation" or "Noninvasive Ventilatory Support"?

    Bach JR, Pham H

    American journal of physical medicine & rehabilitation 2022; (101(4)):400-404 doi:10.1097/PHM.0000000000001905.

    PMID: 34657086
  4. 4

    2022 Year in Review: Mechanical Insufflation-Exsufflation.

    Willis LD

    Respiratory care 2023; (68(2)):275-283 doi:10.4187/respcare.10423.

    PMID: 39889140
  5. 5

    Optimizing Mechanical Insufflation-Exsufflation - Much More than Cough Peak Flow.

    Branson RD, Benditt JO

    Respiratory care 2020; (65(2)):265-268 doi:10.4187/respcare.07682.

    PMID: 31988254
  6. 6

    Characteristics and feasibility of ambulatory respiratory assessment of paediatric neuromuscular disease: an observational retrospective study.

    Zhang C, Wei CJ, Jin Z, et al.

    The International journal of neuroscience 2023; (133(9)):1045-1054 doi:10.1080/00207454.2022.2042691.

    PMID: 35289716
  7. 7

    Dropped head congenital muscular dystrophy caused by de novo mutations in LMNA.

    Karaoglu P, Quizon N, Pergande M, et al.

    Brain & development 2017; (39(4)):361-364 doi:10.1016/j.braindev.2016.11.002.

    PMID: 27876398
  8. 8

    Importance of early diagnosis in LMNA-related muscular dystrophy for cardiac surveillance.

    Choi SA, Cho A, Kim SY, et al.

    Muscle & nerve 2019; (60(6)):668-672 doi:10.1002/mus.26700.

    PMID: 31498906
  9. 9

    Congenital LMNA-Related Muscular Dystrophy in Paediatrics: Cardiac Management in Monozygotic Twins.

    Martínez Olorón P, Alegría I, Cesar S, et al.

    International journal of molecular sciences 2024; (25(11)) doi:10.3390/ijms25115836.

    PMID: 38892025
  10. 10

    The most severe form of LMNA-associated congenital muscular dystrophy.

    Murofushi Y, Hayakawa I, Abe Y, et al.

    Brain & development 2022; (44(9)):650-654 doi:10.1016/j.braindev.2022.05.006.

    PMID: 35729056
  11. 11

    New Guidelines of Pediatric Cardiac Implantable Electronic Devices: What Is Changing in Clinical Practice?

    Silvetti MS, Colonna D, Gabbarini F, et al.

    Journal of cardiovascular development and disease 2024; (11(4)) doi:10.3390/jcdd11040099.

    PMID: 38667717
  12. 12

    Percutaneous endoscopic gastrostomy in children: A single center experience in Saudi Arabia.

    Alhaffaf FA, Alqahtani AS, Alrobyan AA, et al.

    Saudi medical journal 2021; (42(2)):205-208 doi:10.15537/smj.2021.2.25692.

    PMID: 33563740
  13. 13

    Safety and outcomes of percutaneous endoscopic gastrostomy tubes in children.

    Khdair Ahmad F, Younes D, Al Darwish MB, et al.

    Clinical nutrition ESPEN 2020; (38()):160-164 doi:10.1016/j.clnesp.2020.05.011.

    PMID: 32690151
  14. 14

    Percutaneous Endoscopic Gastrostomy and Nutritional Interventions by the Pediatric Nutritional Support Team Improve the Nutritional Status of Neurologically Impaired Children.

    Suh CR, Kim W, Eun BL, Shim JO

    Journal of clinical medicine 2020; (9(10)) doi:10.3390/jcm9103295.

    PMID: 33066538
  15. 15

    Operative treatment of severe scoliosis and pelvic obliquity in patients with spinal muscular atrophy: assessment of outcomes and complications.

    Sun H, Huang Y, Dong Y, et al.

    Orphanet journal of rare diseases 2025; (20(1)):174 doi:10.1186/s13023-025-03682-8.

    PMID: 40217273
  16. 16

    The impact of scoliosis surgery on pulmonary function in spinal muscular atrophy: a systematic review.

    Alhammoud A, Othman Y, El-Hawary R, et al.

    Spine deformity 2021; (9(4)):913-921 doi:10.1007/s43390-021-00302-w.

    PMID: 33683640
  17. 17

    The clinical, histologic, and genotypic spectrum of SEPN1-related myopathy: A case series.

    Villar-Quiles RN, von der Hagen M, Métay C, et al.

    Neurology 2020; (95(11)):e1512-e1527 doi:10.1212/WNL.0000000000010327.

    PMID: 32796131
  18. 18

    A difficult airway approach in a merosin-deficient congenital muscular dystrophy patient: a case report.

    Pelicano Paulos J, Artilheiro V, Cruz C, Carneiro AP

    Brazilian journal of anesthesiology (Elsevier) 2023; (73(5)):683-685 doi:10.1016/j.bjane.2021.03.018.

    PMID: 33895222
  19. 19

    [Anesthesia for thoracic surgery in a female patient with Ullrich congenital muscular dystrophy].

    Hachenberg T, Walles T, Lücke E, Schilling T

    Die Anaesthesiologie 2022; (71(10)):784-788 doi:10.1007/s00101-022-01124-9.

    PMID: 35925158
  20. 20

    Spatial proteomics reveals recombinant human laminin-111 restores adhesion signaling to laminin-α2-deficient muscle.

    Hermann HJ, Wuebbles RD, Dagda M, et al.

    JCI insight 2025; (10(22)).

    PMID: 41118381
  21. 21

    Efficient LAMA1 Gene Activation by Epigenome Editing as a Therapeutic Approach for LAMA2-CMD.

    Qin Y, Akbulut T, Mandraju R, et al.

    Human gene therapy 2026; (37(5-6)):210-222 doi:10.1177/10430342251401873.

    PMID: 41439338
  22. 22

    Allele-specific CRISPR-Cas9 editing inactivates a single nucleotide variant associated with collagen VI muscular dystrophy.

    Bolduc V, Sizov K, Brull A, et al.

    Molecular therapy. Nucleic acids 2024; (35(3)):102269 doi:10.1016/j.omtn.2024.102269.

    PMID: 39171142
  23. 23

    Phase 1 Open-Label Study of Omigapil in Patients With LAMA2- or COL6-Related Dystrophy.

    Foley AR, Yun P, Leach ME, et al.

    Neurology. Genetics 2024; (10(3)):e200148 doi:10.1212/NXG.0000000000200148.

    PMID: 38915423

This page is for informational purposes only and does not replace professional medical advice. Always consult your child's multidisciplinary neuromuscular team regarding specific treatments or before undergoing general anesthesia.

Get notified when new evidence is published on Congenital muscular dystrophy.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.